Diamond Bio Fund

Venture Capital Active Taiwan
Last updated 2026-06-18
Portfolio
2
in our dataset
Rounds participated
3
Rounds led
0
Rounds' value
$40.2M
total disclosed, rounds participated
Stages

Portfolio · 2

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences2

Q&A

What is Diamond Bio Fund's primary investment focus?
Diamond Bio Fund primarily focuses its investments within the Health Tech & Life Sciences sector, with all of its portfolio companies and exits falling into this category.
Can you name some of Diamond Bio Fund's portfolio companies?
Diamond Bio Fund's portfolio includes EyeYon Medical, which develops ophthalmic products, and IOPtima, a company focused on surgical ophthalmic laser devices.
What is a notable exit for Diamond Bio Fund?
Diamond Bio Fund had a notable exit in September 2018 with the acquisition of IOPtima by Chengdu Kanghong Pharmaceutical Group for $56M.
What is Diamond Bio Fund's investment stage preference?
Diamond Bio Fund has participated in B Round and C Round funding stages. Specifically, they have two investments in B Rounds and one in a C Round.
When did Diamond Bio Fund make its most recent investment?
Diamond Bio Fund made its most recent recorded investment in March 2021.
Where is Diamond Bio Fund headquartered?
Diamond Bio Fund is headquartered in Taiwan.